← SynDRA
UFENAMATE
SynDRA canonical compound SYN0031496 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PTGS1 | PTGS2 |
|---|
| Mechanism of action | cyclooxygenase inhibitor |
|---|
| Indication | dermatitis | eczema |
|---|
| Disease area | dermatology |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- butyl flufenamate
- fenazol
- flufenamic acid butyl ester
- Ufenamato
- Flufenamic acid butyl ester
- Butyl flufenamate
- Combec
- Fenazol
- Ufenamatum
- 8Z7O7C1SLZ
- RefChem:900977
- DTXCID10815465
- Butyl 2-((3-(trifluoromethyl)phenyl)amino)benzoate
- butyl 2-[3-(trifluoromethyl)anilino]benzoate
- MFCD00866001
- Flufenamic acid butyl ester;Butyl flufenamate
- Butyl N-(3-Trifluoromethylphenyl)anthranilate
- Ufenamatum [Latin]
- Butyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate
- Ufenamato [Spanish]
- N-(3-Trifluoromethylphenyl)anthranilic Acid Butyl Ester
- Ufenamate [INN:JAN]
- HF 264
- Etofenamate EP Impurity B
- UNII-8Z7O7C1SLZ
- BRN 2768727
- Butylflufenamat
- Butyl o-((m-(trifluoromethyl)phenyl)amino)benzoate
- Combec (TN)
- Ufenamate (JAN/INN)
- UFENAMATE [INN]
- UFENAMATE [JAN]
- UFENAMATE [MART.]
- EC 614-050-1
- UFENAMATE [WHO-DD]
- SCHEMBL36095
- Butyl2-((3-(trifluoromethyl)phenyl)amino)benzoate
- orb1302410
Look up UFENAMATE in the interactive SynDRA portal →